Back to Search Start Over

Coriolus Versicolor and Ganoderma Lucidum Related Natural Products as an Adjunct Therapy for Cancers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors :
Zhong, Linda
Yan, Peijing
Lam, Wai Ching
Yao, Liang
Bian, Zhaoxiang
Source :
Frontiers in Pharmacology; 7/3/2019, p1-14, 14p
Publication Year :
2019

Abstract

Background: Cancer incidence and mortality rates keep rising globally. Coriolus versicolor and Ganoderma lucidum related natural products are commonly applied as a complementary therapeutic option for different stages and types of cancers. The aim of this study is to evaluate the efficacy and safety of the products for cancer therapy. Methods: Randomized controlled trials were identified by systematic search over seven databases from inceptions to May 10, 2019. Two independent reviewers extracted data and assessed the study quality. Meta-analyses were performed to pool hazard ratio (HR), risk ratio (RR), mean differences (MD), and 95% CI using random-effects models. The sources of heterogeneity were explored by subgroup analyses and sensitivity analyses. Publication bias was detected by Funnel plots, Begg's test, and Egger's test. Results: Twenty-three trials involving 4,246 cancer patients were included in this work. C. versicolor and G. lucidum related natural products were significantly associated with lower risks of mortality (HR : 0.82; 95% CI : 0.72, 0.94) and higher total efficacy (RR : 1.30; 95% CI : 1.09, 1.55), but not associated with control rate (RR : 1.05; 95% CI : 0.96, 1.14) compared with control treatment. There was no significant difference between C. versicolor related natural products and control treatment in the effect on relapse-free survival (HR : 1.19; 95% CI : 0.91, 1.55). Compared with control treatment, C. versicolor and G. lucidum related natural products had a favorable effect on elevated levels of CD3 (MD : 9.03%; 95% CI : 2.10, 16.50) and CD4 (MD : 9.2%; 95% CI : 1.01, 17.39), but had no effect on the levels of CD8 (MD : −5.52%; 95% CI : −23.17, 12.13), CD4/CD8 (MD : 0.73; 95% CI :-0.45, 1.91), or NK(MD : 5.87%; 95% CI : −1.06, 12.8). Conclusion: In this meta-analysis, we found that C. versicolor and G. lucidum related natural products might have potential benefits on the overall survival and quality of life in cancer patients. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16639812
Database :
Complementary Index
Journal :
Frontiers in Pharmacology
Publication Type :
Academic Journal
Accession number :
137304914
Full Text :
https://doi.org/10.3389/fphar.2019.00703